Close Menu

NEW YORK – Point-of-care diagnostic firm GBS announced on Thursday that it has entered a sponsored research agreement with Johns Hopkins Bloomberg School of Public Health to accelerate the development of saliva-based diagnostic tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.